Blog - Page 1352 of 5712

ThursdayJun 03, 2021 9:39 am

QualityStocksNewsBreaks – Trident Acquisitions Corp. (NASDAQ: TDAC) Announces NASDAQ Notification of Delayed Filing of Quarterly Report

Trident Acquisitions (NASDAQ: TDAC, TDACU, TDACW) announced that it had received a standard notice last month from the listing qualifications staff of the Nasdaq Stock Market LLC. The notice stated that TDAC is not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires companies to file all required periodic financial reports with the Securities Exchange Commission (“SEC”) in a timely manner. TDAC was notified that the company hadn’t filed its quarterly report for the period ending March 31, 2021. The company also noted that in April, the SEC issued a statement providing guidance for all SPAC-related companies regarding the accounting and…

ThursdayJun 03, 2021 9:30 am

Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Notes Impressive Advancement in Cannabis, Functional Mushrooms, Psilocybin Spaces

Pure Extracts’ BC facility is fully operational, ready to meet increasing demand for cannabis-based gummies, vapes, white label products Company’s involvement in functional, psychoactive mushrooms space is also gaining steam Pure Extracts’ current R&D focus is on psychoactive mushroom compounds Although the global pandemic extended its sales cycle, Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) is seeing interest from producers and brands looking for new opportunities and partnerships. Pure Extracts’ CEO Ben Nikolaevsky recently released a corporate update focused on three main points of interest — cannabis, functional mushrooms and psilocybin — in its growing business (https://ibn.fm/0v5sO). The update noted that…

ThursdayJun 03, 2021 9:15 am

DGE’s 2nd Annual Medical Affairs Leadership Forum to Offer a Live Interactive Platform for Medical Professionals

Online Livestreaming Date: June 17-18, 2021 On June 17-18 2021, medical affairs professionals are invited to attend DGE’s 2nd Annual Medical Affairs Leadership Forum to learn successful strategies to derive the maximum out of their work environment, increase job satisfaction, and create a work-life balance. The event is hosted by Dynamic Global Events (“DGE”), a life science leader in organizing B2B events. The world-class event company is an industry trailblazer, meeting the evolving informational and networking needs of the pharmaceutical, biotechnology, healthcare, medical device, and allied industries. Medical Affairs professionals are entrusted with the task of being productive to the organization and…

ThursdayJun 03, 2021 9:15 am

Influencer Marketing Strategies Summit to Share Experiences from Digital Marketing Influencers From Around the Globe

Date: June 8-11, 2021 Virtual Conference The Influencer Marketing Strategies Summit will be held from June 8-10, 2021. Brands, marketers, entrepreneurs, investors, and individuals looking to grow their online presence are invited to attend this virtual event. This global Summit is a one-of-a-kind event that will cover an entire spectrum of topics to launch, scale, and measure influencer programs. The event is co-hosted with Social Media Strategies Summit. The Summit will witness keynotes and discussion sessions from experienced speakers who are well-known influencers in their niche area. Marketers can get their influencer queries answered in the Q&A Sessions and learn…

ThursdayJun 03, 2021 9:15 am

BAND Royalty Disrupts Music Industry By Buying Royalty Rights to Justin Timberlake’s Multi-platinum song “Mirrors” and Attaching it to NFTs

BAND Royalty has successfully bought the performance royalty rights to Justin Timberlake's multi-platinum song “Mirrors”, along with the performance royalty rights to 50+ other songs performed by JayZ, Beyonce, Timbaland, Cher, Demi Lovato, and many more. in a bold move they are giving anyone the ability to enter the secretive world of royalty investing by letting them share in the revenue from these royalty rights when they buy a BAND Royalty NFT for as little as 1 Ethereum. NFTs are built like cryptocurrency, such as Bitcoin or Ethereum, but are non-fungible, meaning that they have a unique digital signature which…

ThursdayJun 03, 2021 9:00 am

FingerMotion Inc. (FNGR) Big Data Insights Arm, Sapientus, Represents Future Potential For Data-Driven Solutions Amid Shortfall of Data Experts

FingerMotion (OTCQX: FNGR) a mobile data and services company, is developing additional value-added technologies to expand its user base to over 1 billion users in China and other regional markets FingerMotion’s Data Insights platform Sapientus delivers data-driven solutions to the insurance and financial services industries Sapientus entered into a services agreement with Pacific Life Re, a global life reinsurer to deliver more efficient and customized solutions to the wider insurance ecosystem FingerMotion (OTCQX: FNGR) is a mobile payment and recharge platform serving markets in China, evolving rapidly by using core competencies. With offices in Hong Kong, Shanghai, and New York,…

ThursdayJun 03, 2021 9:00 am

Friendable Inc. (FDBL) Implements 120-Day Strategy as Fan Pass Prepares for v2 Release

Friendable has ten successful months of growth with the Fan Pass platform, including an increase of 188% in new artist sign-ups since the beginning of the year. The company will be shifting all attention to its Fan Pass platform The global streaming video market was valued at $50.11 billion in 2020. This number is expected to grow at a CAGR of 21% through 2028. Over the next 120 days and through the remainder of 2021, mobile technology and marketing company Friendable (OTC: FDBL) will be implementing a new strategy designed to ensure sustained and continued growth, consisting of the launch…

ThursdayJun 03, 2021 9:00 am

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Targets Academic Collaborations to Advance Research on Largely Ignored Indications for Psilocybin

Psychedelics have been on the receiving end of groundbreaking research, which have greatly influenced the medical acceptance of the compounds Pharmaceutical developer Tryp Therapeutics is looking to use existing preclinical and clinical data to proceed directly to Phase 2a clinical trials The company intends to contribute to the growing body of research through academic collaborations with leading American institutions The research will focus on indications that other pharmaceutical companies have largely ignored Although we can accurately describe the psychedelics industry as nascent, psychedelics have been the subject of a flurry of groundbreaking research that have gradually lifted the stigma surrounding…

WednesdayJun 02, 2021 1:38 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Nears Dosing of Phase 2 Patients with Standout Anthracycline Therapy

CNS Pharmaceuticals (NASDAQ: CNSP) is focused on producing a treatment that improves on the effectiveness of established chemotherapy drug lomustine in increasing overall survival rates of glioblastoma multiforme (“GBM”) patients. GBM is an illness that is nearly 100% fatal in patients just over a year after diagnosis. CNS Pharmaceuticals’ lead drug candidate, Berubicin, has been granted investigational new drug (“IND”) status after promising findings. “Berubicin is a standout anthracycline therapy because of its novel apparent ability to cross the blood-brain barrier to combat neurological tumors. The drug was the subject of a Phase I trial some 15 years ago in…

WednesdayJun 02, 2021 1:22 pm

QualityStocksNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Building Strong Commercial Pipeline for Unique PeDAL(TM) Platform

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, continues to create value for a growing customer base through its subsidiaries. Researchers from one such subsidiary, Helomics, recently completed key sequencing milestones for ovarian cancer to help build its AI-driven models of the disease. “We are building a strong commercial pipeline for our unique Patient-cEntric Discovery by Active Learning (PeDAL)(TM), which we launched at the beginning of 2021,” POAI CEO J. Melville Engle was quoted in a recent article. “PeDAL brings together the key Helomics assets of real-world longitudinal data…

Site Search

Company Search

QualityStocksNewsBreaks – Trident Acquisitions Corp. (NASDAQ: TDAC) Announces NASDAQ Notification of Delayed Filing of Quarterly Report

Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Notes Impressive Advancement in Cannabis, Functional Mushrooms, Psilocybin Spaces

DGE’s 2nd Annual Medical Affairs Leadership Forum to Offer a Live Interactive Platform for Medical Professionals

Influencer Marketing Strategies Summit to Share Experiences from Digital Marketing Influencers From Around the Globe

BAND Royalty Disrupts Music Industry By Buying Royalty Rights to Justin Timberlake’s Multi-platinum song “Mirrors” and Attaching it to NFTs

FingerMotion Inc. (FNGR) Big Data Insights Arm, Sapientus, Represents Future Potential For Data-Driven Solutions Amid Shortfall of Data Experts

Friendable Inc. (FDBL) Implements 120-Day Strategy as Fan Pass Prepares for v2 Release

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Targets Academic Collaborations to Advance Research on Largely Ignored Indications for Psilocybin

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Nears Dosing of Phase 2 Patients with Standout Anthracycline Therapy

QualityStocksNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Building Strong Commercial Pipeline for Unique PeDAL(TM) Platform

Market Basics

Newsletter Publishers

Public Companies